Search
for

    Sort by

    Research 30 of 1000+

    1. A new compound heterozygous frameshift mutation in the type II 3 beta-hydroxysteroid dehydrogenase (3 beta-HSD) gene causes salt-wasting 3 beta-HSD deficiency congenital adrenal hyperplasia. The Journal of Clinical Endocrinology & Metabolism · 1996 · 29 citations
    2. Iatrogenic Cushing's Syndrome in a Patient With Salt-Wasting Congenital Adrenal Hyperplasia (SWCAH) Journal of pediatric nursing · 2011
    3. Congenital adrenal hyperplasia Dermatologic Therapy · 2008 · 16 citations
    4. Congenital Adrenal Hyperplasia Pediatrics in Review · 2009 · 13 citations
    5. Approaching fertility in congenital adrenal hyperplasia: exploring P30L mutation-induced 21-hydroxylase deficiency with a presentation between non-classical and simple virilizing phenotypes. A case report Medicine and Pharmacy Reports · 2023
    6. Clinical, Biochemical and Molecular Characteristics of Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Deficiency Journal of Clinical Research in Pediatric Endocrinology · 2024
    7. Common Forms of Congenital Adrenal Hyperplasia Elsevier eBooks · 2017
    8. Comparison of wiping methods for the removal of cleaning agent residue from hair follicles Skin research and technology · 2019 · 3 citations
    9. Reproductive outcomes of female patients with congenital adrenal hyperplasia due to 21-hydroxylase defi ciency Indian Journal of Endocrinology and Metabolism · 2013 · 14 citations
    10. Genotype–Phenotype Correlation in Children With Congenital Adrenal Hyperplasia due to 21‐Hydroxylase Deficiency Using Next Generation Sequencing Molecular Genetics & Genomic Medicine · 2025
    11. Mister XX Medicinski glasnik Specijalne bolnice za bolesti štitaste žlezde i bolesti metabolizma · 2016 · 1 citations
    12. Posters Presented at the 19th Joint Meeting of the International Society of Dermatopathology, March 2–3, 2016, Hilton Crystal City at Washington Reagan National Airport, Arlington, Virginia, USA American Journal of Dermatopathology · 2016
    13. Topical 2% tofacitinib for children with alopecia areata, alopecia totalis, and alopecia universalis Journal of the American Academy of Dermatology · 2018 · 49 citations
    14. An Open-Label Pilot Study to Evaluate the Efficacy of Tofacitinib in Moderate to Severe Patch-Type Alopecia Areata, Totalis, and Universalis Journal of Investigative Dermatology · 2018 · 130 citations
    15. Rebound effect associated with JAK inhibitor use in the treatment of alopecia areata Journal of the European Academy of Dermatology and Venereology · 2018 · 11 citations
    16. Addisonian crisis in a young man with atypical anorexia nervosa Nature Reviews Endocrinology · 2010 · 13 citations
    17. Safety and efficacy of the JAK inhibitor tofacitinib citrate in patients with alopecia areata JCI insight · 2016 · 222 citations
    18. Objective outcome measures: Collecting meaningful data on alopecia areata Journal of The American Academy of Dermatology · 2017 · 39 citations
    19. Alopecia areata: A review Journal of the Saudi Society of Dermatology & Dermatologic Surgery · 2013 · 29 citations
    20. Quality of life in patients with alopecia areata: a hospital‐based cross‐sectional study Journal of the European Academy of Dermatology and Venereology · 2015 · 25 citations
    21. The Application of Radiochemical Techniques to the Study of the Interaction of Hair Fibers with Aqueous Solutions Textile Research Journal · 1954 · 14 citations
    22. The Interaction of Hair Fibers with Alkali Bromide Solutions Textile Research Journal · 1954 · 12 citations
    23. Bridging psychoneuroimmunology and homeopathy: Modulating the cellular and emotional cascades in refractory alopecia International Journal of Homoeopathic Sciences · 2026
    24. Efficacy, safety and dose response of STS01, a topical controlled release nanoparticle formulation (dithranol/Prosilic), in adults with mild to moderate patchy alopecia areata: A randomised, double-blind, multicentre, phase 2 trial medRxiv · 2026
    25. Quaternary Ammonium Salt-Modified Isabgol (Psyllium) Scaffold as an Antibacterial Dressing for Improved Wound Healing bioRxiv (Cold Spring Harbor Laboratory) · 2022 · 2 citations
    26. Topically applied N,N-Dimethylglycine Sodium Salt Enhances Human Skin Blood Flow by Inducing Endothelial Nitric Oxide Release 2024
    27. N,N-Dimethylglycine Sodium Salt Exerts Marked Anti-Inflammatory Effects in Various Dermatitis Models and Activates Human Epidermal Keratinocytes by Increasing Proliferation, Migration, and Growth Factor Release International Journal of Molecular Sciences · 2023
    28. Fusarium sp. Strain K-23 Alleviates Salt Stress in Arabidopsis thaliana Through its Root Hair Growth-Promoting Effect Journal of Plant Growth Regulation · 2024
    29. Long‐term safety and efficacy of ritlecitinib in adults and adolescents with alopecia areata and at least 25% scalp hair loss: Results from the ALLEGRO‐LT phase 3, open‐label study Journal of the European Academy of Dermatology and Venereology · 2025 · 15 citations
    30. Comparative Efficacy and Safety of Baricitinib Against Traditional Therapies in Severe Alopecia Areata: A Retrospective Cohort Study Journal of Cosmetic Dermatology · 2024